31113777Chari A, Martinez-Lopez J, Mateos MV, Bladé J, Benboubker L, Oriol A, Arnulf B, Rodriguez-Otero P, Pineiro L, Jakubowiak A, de Boer C, Wang J, Clemens PL, Ukropec J, Schecter J, Lonial S, Moreau PBloodAntineoplastic Combined Chemotherapy Protocols; Multiple MyelomaAdult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Dexamethasone; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Oligopeptides; Prognosis; Recurrence; Retreatment; Survival Analysis; Treatment OutcomeDaratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma. Blood. 2019 08 01; 134(5):421-431.Blood2019-05-21T00:00:002019Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461329Aged, 80 and overD000368Living Beings1341183530.29479AgedD000328Living Beings1578255770.254454AdultD000971Procedures30624340.47627Antineoplastic Combined Chemotherapy ProtocolsD000911Chemicals & Drugs33713760.622785Antibodies, MonoclonalD003907Chemicals & Drugs1313260.864786DexamethasoneAuthorship 12978530.1785380.1785381authors10.2518has subject areaD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD009842Chemicals & Drugs921790.901844OligopeptidesD005260Physiology1992444050.191184FemaleD012008Phenomena39011370.784621RecurrenceD006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleD019008Physiology1805890.751147Drug Resistance, NeoplasmMedicine-Hematology and OncologyD009101Disorders823070.737453Multiple MyelomaD016896Concepts & Ideas101179490.402421Treatment OutcomeD019233Procedures701070.968761RetreatmentD011379Procedures74536690.561484PrognosisD016019Concepts & Ideas43415360.742939Survival AnalysisUniversity of ChicagoAndrzejJakubowiak1mhjCqp1G+POmHtvQFPt+2z5/syyp7BaZQ==Andrzej Jakubowiak41.78927490000000-87.601250000000002384Jakubowiak, AndrzejProfessortrue1ProfessorProfessor